Literature DB >> 9513205

[Effects of L-threo-Dops on orthostatic hypotension in Parkinson's disease].

N Yanagisawa1, S Ikeda, T Hashimoto, N Hanyu, S Nakagawa, N Fujimori, M Ushiyama.   

Abstract

Effects of L-threo-Dops (Dops) administration on orthostatic hypotention were evaluated with changes in blood pressure by postural change (lying to standing position) and subjective symptoms in 15 patients of Parkinson's disease having symptoms of orthostatic hypotention. Orthostatic syncope had improved significantly (p < 0.01) after 2 and 4 weeks of administration with maintenance dose of 460 mg/day of Dops in average. In the standing-up (Schellong) test, decrease in blood pressure levels by a postural change, both with systolic and diastolic blood pressure, was significantly smaller at 3, 5 and 10 minutes after standing after 4 weeks of drug administration. Decrease in the blood pressure level immediately after standing-up improved by 10.2 +/- 4.0 for systolic and 6.5 +/- 1.8 for diastolic (mmHg, mean +/- SE) (p < 0.01). The group that showed improvement in orthostatic syncope had a significant improvement in decline in blood pressure by standing after administration of Dops, while the group without any change in severity of syncope did not show significant improvement in orthostatic hypotention.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9513205

Source DB:  PubMed          Journal:  No To Shinkei        ISSN: 0006-8969


  2 in total

Review 1.  L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension: the European experience.

Authors:  Christopher J Mathias
Journal:  Clin Auton Res       Date:  2008-03-27       Impact factor: 4.435

Review 2.  Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa.

Authors:  Stuart H Isaacson; Julia Skettini
Journal:  Vasc Health Risk Manag       Date:  2014-04-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.